Related Experiment Video
Updated: Jun 8, 2025
04:09
Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel FilmWound Healing
Published on: December 13, 2024
455
Hydroxamic Acids Derivatives: Greener Synthesis, Antiureolytic Properties and Potential Medicinal Chemistry
Luciana P S Viana1, Luan R Pinheiro1, Lorenzo W Petrillo1
1Departamento de Química, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Current Topics in Medicinal Chemistry
|November 1, 2024
Summary
Hydroxamic acids (HAs) are versatile compounds that inhibit urease enzymes. This review explores their use against ureolytic bacteria like Helicobacter pylori and sustainable synthesis methods.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Organic Chemistry
Background:
- Hydroxamic acids (HAs) possess strong chelating properties due to their unique structure (RCONR'OH).
- They are known inhibitors of metalloenzymes containing Ni(II) and Zn(II).
- HAs were identified as urease inhibitors in 1962, showing potential against ureolytic microorganisms.
Purpose of the Study:
- To systematically review the applications of hydroxamic acids in treating infections caused by ureolytic microorganisms.
- To explore advancements in synthesizing hydroxamic acid derivatives using green chemistry approaches.
Main Methods:
- Literature review focusing on hydroxamic acids as urease inhibitors.
- Analysis of studies investigating HAs against ureolytic pathogens such as Helicobacter pylori and Proteus mirabilis.
- Survey of recent developments in sustainable synthesis of hydroxamic acid derivatives.
Main Results:
- Hydroxamic acids demonstrate significant potential in inhibiting urease, a key enzyme in infections caused by ureolytic bacteria.
- Their chelating ability and enzyme inhibition properties are central to their therapeutic applications.
- Emerging research highlights environmentally friendly methods for producing diverse hydroxamic acid derivatives.
Conclusions:
- Hydroxamic acids are promising therapeutic agents against infections mediated by ureolytic microorganisms.
- Further research into their medicinal applications and sustainable synthesis is warranted.
- This review bridges a gap in the literature concerning HAs for treating ureolytic infections.
Keywords:
Greener synthesisHelicobacter pyloriHydroxamic acidsMedicinal applicationsMicroorganisms.Urease inhibitorsMore Related Videos
Related Concept Videos
01:15Phase I Reactions: Hydrolytic Reactions
78
Hydrolysis, a cornerstone of phase I biotransformation reactions, uses water to cleave chemical bonds. This process is pivotal in drug metabolism, generating more polar metabolites that can be easily excreted.
An important hydrolytic reaction is ester hydrolysis. Ester bonds, often found in prodrugs, are broken down, increasing the solubility of drugs like aspirin and lidocaine for more straightforward elimination. Amide hydrolysis is another critical reaction, targeting amide bonds prevalent...
An important hydrolytic reaction is ester hydrolysis. Ester bonds, often found in prodrugs, are broken down, increasing the solubility of drugs like aspirin and lidocaine for more straightforward elimination. Amide hydrolysis is another critical reaction, targeting amide bonds prevalent...
78
01:29Preparation of Amines: Reduction of Oximes and Nitro Compounds
3.4K
Oximes can be reduced to primary amines using catalytic hydrogenation, hydride reduction, or sodium metal reduction. The reduction of aliphatic and aromatic nitro compounds to primary amines takes place by either catalytic hydrogenation or by using active metals like Fe, Zn, and Sn in the presence of an acid.
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
3.4K
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
407
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
407
01:19Reactions of Acid Anhydrides
4.1K
The reactions of acid anhydrides are analogous to the reactions of acid chlorides and proceed via a nucleophilic acyl substitution. They only differ in the identity of the leaving group. During an acid chloride reaction, the leaving group is a chloride ion, and the by-product is hydrochloric acid. However, in an acid anhydride reaction, the leaving group is a carboxylate ion, and the by-product is a carboxylic acid.
4.1K
01:28Amides to Carboxylic Acids: Hydrolysis
3.1K
Amides can undergo either acid-catalyzed hydrolysis or base-promoted hydrolysis through a typical nucleophilic acyl substitution. Each hydrolysis requires severe conditions.
Acid-catalyzed hydrolysis:
Hydrolysis of amides under acidic conditions yields carboxylic acids. Since the reaction occurs slowly, hydrolysis requires the conditions of heat.
The mechanism begins with the protonation of the carbonyl oxygen by the acid catalyst. The protonation makes the amide carbonyl carbon more...
Acid-catalyzed hydrolysis:
Hydrolysis of amides under acidic conditions yields carboxylic acids. Since the reaction occurs slowly, hydrolysis requires the conditions of heat.
The mechanism begins with the protonation of the carbonyl oxygen by the acid catalyst. The protonation makes the amide carbonyl carbon more...
3.1K
01:26Cholinergic Antagonists: Therapeutic Uses
716
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
716